Immunovant
IMVT
IMVT
119 hedge funds and large institutions have $293M invested in Immunovant in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 41 increasing their positions, 40 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9.98% less ownership
Funds ownership: 39.35% → 29.38% (-10%)
28% less capital invested
Capital invested by funds: $407M → $293M (-$114M)
Holders
119
Holding in Top 10
1
Calls
$47.9M
Puts
$3.48M
Top Buyers
| 1 | +$13.7M | |
| 2 | +$9.91M | |
| 3 | +$8.69M | |
| 4 |
PIM
Platinum Investment Management
Sydney Australia 2000,
Australia
|
+$4.82M |
| 5 |
FM
Frazier Management
Seattle,
Washington
|
+$2.88M |
Top Sellers
| 1 | -$30.5M | |
| 2 | -$13.5M | |
| 3 | -$10.6M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$7.32M |
| 5 |
OFCM
One Fin Capital Management
San Francisco,
California
|
-$6.47M |